Use of ECMO in Acute MI
Launched by JOHANN WOLFGANG GOETHE UNIVERSITY HOSPITAL · Jan 22, 2007
Trial Information
Current as of June 20, 2025
Unknown status
Keywords
ClinConnect Summary
Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute MI
- Exclusion Criteria:
- • Contraindication against ECMO
About Johann Wolfgang Goethe University Hospital
Johann Wolfgang Goethe University Hospital, located in Frankfurt am Main, Germany, is a prominent academic medical center affiliated with Goethe University. Renowned for its commitment to advancing healthcare through innovative research and clinical excellence, the hospital serves as a vital hub for clinical trials and medical studies. It integrates cutting-edge technology with a multidisciplinary approach, facilitating collaboration among healthcare professionals to enhance patient outcomes. The hospital is dedicated to ethical research practices and adheres to stringent regulatory standards, ensuring the safety and well-being of trial participants while contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Farhad Bakhtiary, MD
Principal Investigator
JW Goethe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials